3-185672570-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006548.6(IGF2BP2):c.1171C>T(p.Pro391Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,612,540 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006548.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGF2BP2 | NM_006548.6 | c.1171C>T | p.Pro391Ser | missense_variant | 10/16 | ENST00000382199.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGF2BP2 | ENST00000382199.7 | c.1171C>T | p.Pro391Ser | missense_variant | 10/16 | 1 | NM_006548.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000101 AC: 25AN: 248636Hom.: 0 AF XY: 0.0000742 AC XY: 10AN XY: 134714
GnomAD4 exome AF: 0.0000555 AC: 81AN: 1460452Hom.: 1 Cov.: 31 AF XY: 0.0000592 AC XY: 43AN XY: 726544
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74274
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 08, 2024 | The c.1171C>T (p.P391S) alteration is located in exon 10 (coding exon 10) of the IGF2BP2 gene. This alteration results from a C to T substitution at nucleotide position 1171, causing the proline (P) at amino acid position 391 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at